LIVE Webinar
Wednesday, November 17, 2021
3:00 - 4:30 PM Eastern Time
In a growing number of people who contract COVID-19, symptoms persist long after the initial SARS-CoV-2 infection subsides. COVID-19 and long COVID patients display a variety of symptoms that reveal SARS-CoV-2’s versatility and its long-lasting impact on organ function. While this heterogeneity makes it difficult to study the disease, scientists apply every available technology to investigate the virus’ pathological mechanisms. In this webinar brought to you by Cayman Chemical, Floyd Chilton and Thomas Bumol will discuss how they combine metabolomics, transcriptomics, and immune profiling to study SARS-CoV-2’s ability to attack multiple organs, even after the virus has been cleared from the body.
Topics to be covered
- Molecular networks and enzymes that determine COVID-19 mortality
- Persistent inflammatory signatures in long COVID
Meet the Speakers:
Floyd (Ski) H. Chilton, PhD
Professor, School of Nutritional Sciences and Wellness
Director, Precision Nutrition and Wellness Initiative
The University of Arizona
Thomas F. Bumol, PhD
Executive Vice President and Director
Allen Institute for Immunology
